NLRP3 inflammasome in digestive diseases: From mechanism to therapy

Front Immunol. 2022 Oct 26:13:978190. doi: 10.3389/fimmu.2022.978190. eCollection 2022.

Abstract

Digestive system diseases remain a formidable challenge to human health. NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome is the most characteristic multimeric protein complex and is involved in a wide range of digestive diseases as intracellular innate immune sensors. It has emerged as a research hotspot in recent years. In this context, we provide a comprehensive review of NLRP3 inflammasome priming and activation in the pathogenesis of digestive diseases, including clinical and preclinical studies. Moreover, the scientific evidence of small-molecule chemical drugs, biologics, and phytochemicals, which acts on different steps of the NLRP3 inflammasome, is reviewed. Above all, deep interrogation of the NLRP3 inflammasome is a better insight of the pathomechanism of digestive diseases. We believe that the NLRP3 inflammasome will hold promise as a novel valuable target and research direction for treating digestive disorders.

Keywords: NLRP3 inflammasome; biologics; digestive system diseases; phytochemicals; small-molecule chemical drugs.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Digestive System Diseases* / drug therapy
  • Humans
  • Inflammasomes* / metabolism
  • NLR Family, Pyrin Domain-Containing 3 Protein / metabolism
  • Phytochemicals

Substances

  • Inflammasomes
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Phytochemicals